Illumavista Biosciences LLC has established operations in the University Research Park. Founded in 2010 by C. Warrren and M. Ozer, the company offers bioinformatic services and is developing microarray technology to assess protein expression.
Echogen iNC., an early stage company headquartered in Kansas, has opened a research lab in the University Research Park. The company is developing technologies for cancer therapeutics and other applications.
BioSystem Development has agreed to be acquired by Agilent Technologies of Santa Clara, CA. Purchase price was not disclosed. Closing is expected by year-end 2011.
Lifegen technologies, llc was acquired by Nu Skin Enterprises of Utah in December 2011 for $11.7 million.
Roche Madison INc. was purchased in October 2011 by Arrowhead Research Corporation, along with related RNAi intellectual property owned by Roche. Roche received a minority interest in Arrowhead, received first right to negotiate licenses on up to 8 products, and will be eligible to receive royalties and milestones. The company name has been changed to
Arrowhead madison.
TRAC Microbiology announced in August 2011 that it was being purchased by Covance. Terms were undisclosed.
TREK diagnostic Systems was sold in July 2011 by Magellan Biosciences to Thermo Fisher Scientific.
EraGen Biosciences was acquired by Luminex Corporation for $34 million, and will continue to operate in Madison. The transaction closed in June 2011.
ASthmapolis was founded in 2010 to commercialize asthma related technologies. Its lead product, Spiroscout, is an GPS enabled inhaler that automatically tracks and reports its use.
SHINE MEDICAL TECHNOLOGIES was spun out from Phoenix Nuclear Labs in 2010 to commercialize its low cost production process for molybdenum-99, an isotope used in cardiovascular and cancer imaging. The company completed an $11 million financing in June 2011.
CoMMET, LLC is a company that develops multifunctional meta-materials, including tactile sensing materials that could be used in medical applications. Founded in 2009, the company was added to our database in June 2011.
Cellectar Inc. has merged with Novelos Therapeutics Inc., a public traded company. Cellectar shareholders received approximately 85% of the combined company. The new Novelos will be headquartered in Madison, with a secondary office in Boston. The company's focus will be on Cellectar's three cancer programs. Venture Investors led a concurrent $5.1 million financing.
Cellscript, Inc., formerly an affiliate of EpiCentre Biotechnologies, has been spun out as an independent company led by CEO Gary Dahl, PhD. CellScript focuses on technologies and products for translation of RNA in cells for clinical research and therapeutics.
Tomotherapy Inc. announced on March 7, 2011 that Accuray Inc. would acquire the company for $277 million in cash and stock. The transaction is expected to close in Q2. Accuray is a publicly traded radiosurgery company based in the San Francisco area. It is anticipated that R&D and manufacturing operations will continue in Madison, among other functions.
nerites corporation announced that Kensey Nash Corporation, a publicly traded regenerative medicine company, acquired the assets of the company on January 31, 2011 for $20 million. The Madison research site will continue under the Kensey Nash brand.
Epicentre biotechnologies announced on January 11, 2011 that it has been acquired by Illumina Inc., a leading life sciences research products company based in San Diego.
Procyon Pharmaceuticals Inc. has changed its name to
Nexcyon Pharmaceuticals Inc.
Nanooncology inc., founded in 2010, is developing novel siRNA therapeutics to treat cancer. It was founded by Drs. Tom Primiano and Lonnie Bookbinder.
PercipEnz Technologies Inc., a leader in clinical trials management systems, changed its name in September 2010 to
Forte Research Systems Inc.
Stablebody technologies LLC, founded in 2009, is commercializing a novel technology to stabilize antibodies. The company is headquartered in Middleton, with labs in Chicago.
Microbial BioSynthesis LLC is a newly established genetic engineering and pharmaceutical discovery company, founded by Ena Urbach PhD, focused on producing new compounds from soil microorganisms.
Zurex Pharma Inc. is a medical technology and specialty pharma company which has established its headquarters in Madison. Zurex is developing a portfolio of late stage anti-infective products designed to prevent healthcare acquired infections.
AlliedPanels North America, a company that engineers and manufactures medical device components and systems for the healthcare industry, was added to the database. Founded in 2008, it is a business unit of its Austrian parent.
BIOFerm Energy Systems is a renewable energy company that designs and constructs biogas plants in North America. BIOFerm is based upon a dry fermentation digestion system. Founded in 2007, it is a subsidiary of Germany's BIOFerm GmbH, part of the Viessmann Group.
Im-bed biosciences is a virtual, startup company founded to develop and commercialize novel bioactive wound dressings integrated with stabilized loadings of antibacterial silver nanoparticles. The company, which won the 2010 Burrill Business Plan Competition and placed second in the Governor's Business Plan Competition, has been added to the database.
Imago Scientific instruments Corporation was acquired by AMETEK Inc. for $6 million in April 2010. AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices based in Pennsylvania with annual sales of $2.1 billion. The company continued operations in Madison as CAMECA Instruments Inc.
Invivo Sciences has established its corporate office at 510 Charmany Drive, Suite 165. (Dec 2011)
Kensey Nash Corporation - Wisconsin (formerly Nerites Corp.) relocated to 505 S. Rosa Road, Suite 123 from Science Drive. (Mar 2011)
Flex Biomedical Inc. relocated from the University Research Park to 555 D'Onofrio Drive, Suite 102 in Madison (Feb 2011)
Compact Particle Acceleration Corporation closed its Madison location to concentrate operations at its Livermore, CA research facility. (2010)
Quincy bioscience relocated from the University Research Park to 301 S. Westfield Road, Suite 200 in Madison (June 2010)
nPoint relocated from Sherman Avenue to 3030 Laura Lane, Suite 100 in Middleton (May 2010)
Next Generation Clinical Research relocated to 3000 Cahill Main, Suite 214 in Fitchburg (May 2010)
SAFC Pharma has opened its new $30 million API manufacturing facility in Verona (Apr 2010).
Click for Press Release